Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2025-12-29 @ 5:16 PM
Study NCT ID:
NCT01063803
Status:
COMPLETED
Last Update Posted:
2016-04-11
First Post:
2010-02-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis
Sponsor:
Ablynx, a Sanofi company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-02
First Submit QC Date:
None
Study First Post Date:
2010-02-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-01-31
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-03-10
Last Update Post Date:
2016-04-11
Last Update Post Date Type:
ESTIMATED